EMA starts contraceptive safety review
January 30, 2013Manufacturing and Production, Sales and Marketing EMA, PRAC, VTE, contraception
Europe’s health regulator is to examine the safety of newer forms of contraceptive pills following concerns over potential health risks …
Merck signs lupus research deal
January 30, 2013Research and Development, Sales and Marketing Feinstein, Merck Serono, SLE
Merck Serono and the Feinstein Institute for Medical Research in New York are to collaborate on antibodies to treat systemic …
Oxyrane brings on board senior team
January 30, 2013Manufacturing and Production, Research and Development, Sales and Marketing Oxyrane, biotech
UK biotech firm Oxyrane has expanded to the US and made a number of senior appointments. The privately-owned Manchester-based company’s first …
Succinct and Royal Marsden launch new partnership
January 29, 2013Medical Communications, Research and Development, Sales and Marketing NHS, Succinct, royal marsden
Communications agency Succinct has unveiled a new innovative NHS/industry partnership with The Royal Marsden hospital, one of Europe’s leading cancer …
AstraZeneca signs respiratory deal
January 29, 2013Research and Development, Sales and Marketing AstraZeneca, COPD, orexo, respiratory
AstraZeneca has signed a research deal with Swedish pharma company Orexo centred around the development of respiratory disease treatments. For …
Payments register moves closer
January 29, 2013Sales and Marketing Bad pharma, Goldacre, NHS, doctors, pharma
Greater transparency around the payments made by pharma companies to doctors looks to have moved a step closer with a …
Lonza says 2012 growth was solid, but more restructuring due
January 29, 2013Manufacturing and Production Arch, CMO, Lonza
Swiss contract manufacturing organisation (CMO) and ingredients supplier Lonza posted a 46% increase in revenues to 3.93 billion francs last …
Synthon opens ADC plant in the Netherlands
January 29, 2013Manufacturing and Production ADC, Synthon
Synthon Biopharmaceuticals says it has opened officially opened a new antibody-drug conjugate (ADC) manufacturing facility in Nijmegen, the Netherlands. The …
Boehringer calls for ‘game changing’ ideas in health
January 29, 2013Medical Communications, Research and Development, Sales and Marketing Ashoka Changemakers, Boehringer Ingelheim
Boehringer Ingelheim has teamed up with a social entrepreneur network to promote health projects in developing countries. This is the …
New government chairman for pharmacy programme board
January 29, 2013Manufacturing and Production, Medical Communications, Sales and Marketing Ken Jarrold, NHS, government
The Department of Health has announced the appointment of Ken Jarrold to chair the programme board for the government’s work …
NICE hits back at ‘limited’ EC study
January 28, 2013Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead
NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …
Takeda gets US diabetes approval
January 28, 2013Sales and Marketing FDA, Nesina, Takeda, diabetes
Takeda has been given US approval for its diabetes drug Nesina and two variations on it for the treatment of …
NHS patient data and clinical research – coming together at last?
January 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, NHS, R&D, clinical, records, transparency
In the mid-1990s, an NHS teaching hospital close to my offices invited proposals for expanding its clinical trials unit. Hitherto …
GSK appoints Hans Wijers to its Board as a non-executive director
January 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, hans Wijers
GSK has confirmed the appointment of Hans Wijers to its Board as a non-executive director with effect from April. The …
J&J seeks end to Doxil shortage as Ben Venue signs consent decree
January 28, 2013Manufacturing and Production Ben Venue, Boehringer, Caelyx, Doxil, J&J, JJ, Janssen
Johnson & Johnson says it has taken steps to establish new supplies of its cancer drug Doxil/Caelyx, which remains in …
Vaccine manufacturing emerges as outsourcing market
January 28, 2013Manufacturing and Production R&D, Vaccine, outsourcing
Healthy growth in the market for vaccines – coupled with high production costs – look set to create a vaccine …
Life Tech gets bigger in bioproduction with BAC buy
January 28, 2013Manufacturing and Production BAC, Life Technologies
Life Technologies has expanded its position in bioprocessing technologies with the acquisition of Dutch protein purification specialist BAC. Carlsbad, US-based …
Scotland’s medicines bill can shrink further, says report
January 25, 2013Sales and Marketing PPRS, Scotland, VBP, prescribing
An official review of primary care prescribing in Scotland has welcomed savings made, but says further efficiencies are possible.Audit Scotland …
Abbott finishes strongly before spin-off
January 25, 2013Sales and Marketing AbbVie, Abbott, Q4 2012
Abbott has presented its full-year results for 2012 – the last in which many of its products will appear, following …
NICE recommends two cystic fibrosis treatments
January 25, 2013Sales and Marketing Colobreath, Forest Labs, Novartis, Tobi Podhaler, cystic fibrosis
NICE has given final recommendation to two new inhalers for cystic fibrosis (CF) patients.Forest Lab’s Colobreath (colistimethate sodium) and Novartis’ …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
